What is the catalog number for Musashi 1/Msi1 Rabbit Polyclonal Antibody?

The catalog number for Musashi 1/Msi1 Rabbit Polyclonal Antibody is orb19089.

What sizes are available for Musashi 1/Msi1 Rabbit Polyclonal Antibody?

Musashi 1/Msi1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Musashi 1/Msi1 Rabbit Polyclonal Antibody in stock?

Musashi 1/Msi1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Musashi 1/Msi1 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

RNA-binding protein Musashi homolog 1; Musashi-1; MSI1

UniProt

O43347

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the N-terminus of human Musashi 1/Msi1, identical to the related mouse and rat sequences.

Target

RNA-binding protein Musashi homolog 1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cell Biology, Disease Biomarkers, Neuroscience, Stem Cell & Developmental Biology

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Mouse, Rat Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human, Mouse, Rat Immunocytochemistry/Immunofluorescence, 5 μg/ml, Human Flow Cytometry (Fixed), 1-3 μg/1x10^6 cells, Human

Form

Lyophilized

Molecular Weight

39 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, ICC, IF, IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.